Showing results (351-360 of 588) with videos related to

Sort By:
Pageof 59
Plos One|July 16, 2014
Single-stranded DNA catalyzes hybridization of PCR-products to microarray capture probesSimon Dally, Steffen Rupp, Karin Lemuth, et al.
Cancer|July 1, 1989
Blue nevus and nevus of Ota associated with dural melanomaL C Hartmann, G F Oliver, R K Winkelmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 5, 1999
Dendritic cells undergo rapid apoptosis in vitro during antigen-specific interaction with CD4+ T cellsH Matsue, D Edelbaum, A C Hartmann, et al.
International Journal of Systematic and Evolutionary Microbiology|February 21, 2012
Amantichitinum ursilacus gen. nov., sp. nov., a chitin-degrading bacterium isolated from soilKarin S Moß, Stefan C Hartmann, Isabell Müller, et al.
Annals of Surgical Oncology|September 28, 2011
Contralateral prophylactic mastectomy: long-term consistency of satisfaction and adverse effects and the significance of informed decision-making, quality of life, and personality traitsMarlene H Frost, Tanya L Hoskin, Lynn C Hartmann, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 10, 2010
Intraperitoneal LPS amplifies portal hypertension in rat liver fibrosisChristian J Steib, Anna C Hartmann, Christoph v Hesler, et al.
American Journal of Obstetrics and Gynecology|June 18, 2002
Multimodal therapy including neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) for stage IIB to IV cervical cancerSean C Dowdy, Cecelia H Boardman, Timothy O Wilson, et al.
The Biochemical Journal|May 15, 1993
Characterization of phosphoinositide-specific phospholipase C in rat colonocyte membranesM J Bolt, B M Bissonnette, R K Wali, et al.
Breast Cancer Research and Treatment|July 27, 2015
Breast cancer after prophylactic mastectomy (bilateral or contralateral prophylactic mastectomy), a clinical entity: presentation, management, and outcomesRobert W Mutter, Marlene H Frost, Tanya L Hoskin, et al.
Journal of Pharmacokinetics and Biopharmaceutics|August 11, 1991
A pharmacokinetic model describing the removal of circulating radiolabeled antibody by extracorporeal immunoadsorptionC Hartmann, D C Bloedow, D G Dienhart, et al.
Pageof 59